Login:
 
Savill P. Non-major bleeds less frequent in AF patients on apixaban. Practitioner. 2017;261 (1804): 9

Non-major bleeds less frequent in AF patients on apixaban

23 May 2017Pais-up subscribers

Non-major bleeding was substantially less in patients on apixaban compared with those on warfarin in the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. 

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .